Answers are grounded in this paper and cite their sources.
This is the first report showing that BC exosomes contain MTA1 and can transfer it to other cells resulting in changes to hypoxia and estrogen receptor signaling in the tumor microenvironment. These results, collectively, provide evidence suggesting that exosome-mediated transfer of MTA1 contributes to BC progression by modifying cellular responses to important signaling pathways and that exosome-MTA1 may be developed as a biomarker and therapeutic target for BC.
No takes yet. Share an insight, caveat, or question.
Hannafon et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: